Posey D J, McDougle C J
Department of Psychiatry, Indiana University School of Medicine, 541 Clinical Drive, Indianapolis, IN 46202, USA.
Curr Psychiatry Rep. 2001 Apr;3(2):101-8. doi: 10.1007/s11920-001-0006-1.
This article critically reviews research done in the past 2 years concerning the pathophysiology and treatment of autism. Recent research in genetics, neuroimaging, neurochemistry, and pharmacologic treatment has advanced the body of knowledge about the pathophysiology of autism. Relatively new imaging technologies (eg, positron emission tomography) are increasingly being applied to the study of subjects with autism and have produced promising results that await replication. Neurochemical and challenge studies continue to suggest a role for 5-HT dysregulation in autism. Additional research is needed to determine the role of neuroendocrine and autoimmune factors in autism. Significant gains have been made in determining which pharmacologic treatments are efficacious in autism. Additional research is needed on agents that might ameliorate the core and associated symptoms of autism.
本文批判性地回顾了过去两年中关于自闭症病理生理学和治疗的研究。遗传学、神经影像学、神经化学和药物治疗方面的最新研究推进了关于自闭症病理生理学的知识体系。相对较新的成像技术(如正电子发射断层扫描)越来越多地应用于自闭症患者的研究,并产生了有待重复验证的有前景的结果。神经化学和激发研究继续表明5-羟色胺调节异常在自闭症中起作用。需要进一步研究以确定神经内分泌和自身免疫因素在自闭症中的作用。在确定哪些药物治疗对自闭症有效方面已经取得了显著进展。需要对可能改善自闭症核心症状和相关症状的药物进行更多研究。